Loading quotes...
Forecast
The analysts' average price target is €98.25 (+6.67%). The median is €99.49 (+8.01%).
| Buy |
26 |
| Hold |
7 |
| Sell |
0 |
Discussions in the community
There is no discussion about this asset yet.
Start discussionNews Go to news feed
MetLife posts stronger Q2 results and authorizes $3 billion buyback
MetLife reported Q2 adjusted earnings of about $1.6 billion, or $2.43 per share, up 15% year over year, with adjusted return on equity at 17%—the top of its annual target. Every business segment posted higher adjusted earnings, led by Group Benefits (+25%) aided by favorable life underwriting, though management expects mortality trends to normalize. The company returned roughly $1.1 billion to shareholders in the quarter, repurchased about $700 million of common stock and approved an additional $3 billion repurchase authorization. Management said it remains on track to beat its full-year expense-ratio goal while asset-management earnings may finish near the low end of guidance. » More on finance.yahoo.com
MetLife pays quarterly dividend of $0.5925 per share
MetLife’s board of directors approved a third-quarter 2026 dividend of $0.5925 per common share. The dividend will be paid on September 8, 2026 to shareholders of record as of the August 4, 2026 record date. This marks the 13th consecutive year MetLife has raised its dividend; the stock currently yields 2.62% and, at a price of $91.67, is considered undervalued. » More on de.investing.com
Higher-for-longer rates boost MetLife and Prudential
A steady-to-higher interest rate backdrop after the latest Fed meeting is improving investment income for life insurers, benefiting MetLife and Prudential which hold roughly 85% of their portfolios in bonds and mortgages. Higher rates make it easier to meet long-term policy obligations and increase profitability, though unrealized bond losses matter only if holdings are sold. MetLife posted stronger adjusted earnings growth in Q1 2026, while Prudential appears cheaper on price-to-earnings and price-to-book metrics. » More on finance.yahoo.com
MetLife reaches record high of $89.68
MetLife shares rose to a record high of $89.68, reflecting a continued upward trend; market capitalization stands at $57.6 billion and the year-to-date return is 12.11%. The company introduced the Non‑Qualified Assignment Flex Agreement and added a three‑year termination option for immediate annuities to its Guaranteed Income Program. MetLife appointed Chris Aiken as head of real estate equity strategies and elected eleven directors at the annual meeting through 2027. Options trading volume also rose sharply, with particular focus on September put options. » More on de.investing.com
MetLife rises to new 52-week high at $83.85
MetLife shares reached a new 52-week high of $83.85; they are currently trading at $83.90 and the market capitalization is around $53.9 billion. The price-to-earnings ratio is 16.2, the dividend has been increased for 13 consecutive years and the yield is 2.87%. In Q1 2026 adjusted earnings per share were $2.42 (expectation $2.25), while revenue of $19.07 billion missed the $19.43 billion forecast, so analysts see mixed signals; a fair-value analysis classifies the stock as undervalued. » More on de.investing.com
Historical dividends Dividends
All dividend metrics All metricsFinancials
| (EUR) | September 2026 | YoY |
|---|---|---|
| Revenue | 18.12bn | 25.95% |
| Gross profit | 6.09bn | 143.16% |
| Net profit | 2.12bn | 177.17% |
| EBITDA | 2.91bn | 130.23% |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | €58.51bn |
Number of shares | 628.44m |
52-week high/low | €96.52 - €60.90 |
Dividend yield | 2.16% |
Dividends TTM | €2.00 |
Next dividend | €0.53 |
Beta | 0.77 |
P/E ratio | 13.33 |
PEG ratio | 0.30 |
P/B ratio | 2.94 |
P/S ratio | 0.79 |
Company profile
MetLife, Inc., a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements. It also provides pension risk transfers, institutional income annuities, structured settlements, and capital markets investment products; and other products and services, such as life insurance products and funding agreements for funding postretirement benefits, as well as company, bank, or trust-owned life insurance used to finance nonqualified benefit programs for executives. In addition, it provides fixed, indexed-linked, and variable annuities; and pension products; regular savings products; whole and term life, endowments, universal and variable life, and group life products; longevity reinsurance solutions; credit insurance products; and protection against long-term health care services. MetLife, Inc. was founded in 1863 and is headquartered in New York, New York.
| Name | MetLife |
| CEO | Michel Abbas Khalaf |
| Headquarters | New York City,
ny USA |
| Website | |
| Sector | Financials |
| Industry | Insurance |
| IPO | 08/11/2007 |
| Employees | 46,000 |
Ticker symbols
| Exchange | Symbol |
|---|---|
NYSE | MET |
London Stock Exchange | 0K0X.L |
Frankfurt | MWZ.F |
Düsseldorf | MWZ.DU |
London | 0K0X.L |
SIX | MET1.SW |
München | MWZ.MU |
Wien | METL.VI |